{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:22:18Z","timestamp":1790018538399,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","content-domain":{"domain":["nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.numecd.2012.04.011","type":"journal-article","created":{"date-parts":[[2012,6,30]],"date-time":"2012-06-30T13:16:12Z","timestamp":1341062172000},"page":"S19-S24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"S1","title":["Mechanisms and treatment of cancer cachexia"],"prefix":"10.1016","volume":"23","author":[{"given":"J.M.","family":"Argil\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.","family":"L\u00f3pez-Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Busquets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2012.04.011_bib1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"10.1016\/j.numecd.2012.04.011_bib2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/00000441-193211000-00002","article-title":"The immediate cause of death in cancer","volume":"184","author":"Warren","year":"1932","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.numecd.2012.04.011_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/SPC.0b013e3282f34738","article-title":"Mechanisms to explain wasting of muscle and fat in cancer cachexia","volume":"1","author":"Argiles","year":"2007","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.numecd.2012.04.011_bib4","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1126\/science.285.5435.1853","article-title":"Regulation of \u201cnutraceuticals\u201d","volume":"285","author":"Zeisel","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.numecd.2012.04.011_bib5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jamcollsurg.2004.07.014","article-title":"Effects of omega-3 fatty acid supplementation on tumor-bearing rats","volume":"199","author":"Ramos","year":"2004","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.numecd.2012.04.011_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clnu.2010.06.004","article-title":"Nutraceutical inhibition of muscle proteolysis: a role of diallyl sulphide in the treatment of muscle wasting","volume":"30","author":"Olivan","year":"2011","journal-title":"Clin Nutr"},{"key":"10.1016\/j.numecd.2012.04.011_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00520-006-0153-3","article-title":"Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial","volume":"15","author":"Read","year":"2007","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.numecd.2012.04.011_bib8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/SLA.0b013e31819a4789","article-title":"Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial","volume":"249","author":"Ryan","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.numecd.2012.04.011_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drudis.2007.10.008","article-title":"Novel approaches to the treatment of cachexia","volume":"13","author":"Argiles","year":"2008","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.numecd.2012.04.011_bib10","first-page":"2816","article-title":"Working conference on anorexia and cachexia of neoplastic disease","volume":"30","author":"De Wys","year":"1970","journal-title":"Cancer Res"},{"key":"10.1016\/j.numecd.2012.04.011_bib11","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1200\/JCO.1993.11.4.762","article-title":"Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and\/or cachexia","volume":"11","author":"Loprinzi","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.numecd.2012.04.011_bib12","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/1097-0142(19900915)66:6<1279::AID-CNCR2820660630>3.0.CO;2-R","article-title":"A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer","volume":"66","author":"Bruera","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.numecd.2012.04.011_bib13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00001813-199706000-00007","article-title":"Effect of medroxyprogesterone acetate on the quality of life of the oncologic patient: a multicentric cooperative study","volume":"8","author":"Neri","year":"1997","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.numecd.2012.04.011_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-2999(94)90229-1","article-title":"Megestrol acetate stimulates food and water intake in the rat: effects on regional hypothalamic neuropeptide Y concentrations","volume":"265","author":"McCarthy","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.numecd.2012.04.011_bib15","first-page":"657","article-title":"The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (review)","volume":"17","author":"Strang","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1016\/j.numecd.2012.04.011_bib16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0959-8049(96)00486-8","article-title":"Medroxyprogesterone acetate reduces the in\u00a0vitro production of cytokines and serotonin involved in anorexia\/cachexia and emesis by peripheral blood mononuclear cells of cancer patients","volume":"33","author":"Mantovani","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.numecd.2012.04.011_bib17","first-page":"227","article-title":"Palliative treatment of cancer anorexia with oral suspension of megestrol acetate","volume":"50","author":"Tomiska","year":"2003","journal-title":"Neoplasma"},{"key":"10.1016\/j.numecd.2012.04.011_bib18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.clnu.2010.06.003","article-title":"Megestrol acetate: its impact on muscle protein metabolism supports its use in cancer cachexia","volume":"29","author":"Busquets","year":"2010","journal-title":"Clin Nutr"},{"key":"10.1016\/j.numecd.2012.04.011_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2169\/internalmedicine.45.1402","article-title":"Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia","volume":"45","author":"Nagaya","year":"2006","journal-title":"Intern Med"},{"key":"10.1016\/j.numecd.2012.04.011_bib20","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.12-5-594","article-title":"Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers","volume":"12","author":"Garcia","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.numecd.2012.04.011_bib21","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1517\/13543784.14.10.1233","article-title":"The use of melanocortin antagonists in cachexia of chronic disease","volume":"14","author":"Scarlett","year":"2005","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.numecd.2012.04.011_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/ncpendmet0221","article-title":"Therapy insight: use of melanocortin antagonists in the treatment of cachexia in chronic disease","volume":"2","author":"DeBoer","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.numecd.2012.04.011_bib23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1042\/cs0770357","article-title":"Metabolic effects of tumour necrosis factor-alpha (cachectin) and interleukin-1","volume":"77","author":"Evans","year":"1989","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.numecd.2012.04.011_bib24","first-page":"139","article-title":"Effect of FR143430, a novel cytokine suppressive agent, on adenocarcinoma colon26-induced cachexia in mice","volume":"18","author":"Yamamoto","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1016\/j.numecd.2012.04.011_bib25","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.173.3.699","article-title":"Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes","volume":"173","author":"Sampaio","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.numecd.2012.04.011_bib26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/infdis\/168.2.408","article-title":"The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum","volume":"168","author":"Sampaio","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.numecd.2012.04.011_bib27","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/gut.2004.047563","article-title":"Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial","volume":"54","author":"Gordon","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.numecd.2012.04.011_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-5273(02)00470-9","article-title":"How to recover from renaissance? The significance of the results of recover, renaissance, renewal and attach","volume":"86","author":"Anker","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.numecd.2012.04.011_bib29","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1200\/JCO.2005.04.2838","article-title":"Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients","volume":"24","author":"Monk","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.numecd.2012.04.011_bib30","first-page":"18","article-title":"A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia","volume":"6","author":"Wiedenmann","year":"2008","journal-title":"J Support Oncol"},{"key":"10.1016\/j.numecd.2012.04.011_bib31","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1210\/en.136.8.3669","article-title":"Interleukin-15: a novel anabolic cytokine for skeletal muscle","volume":"136","author":"Quinn","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.numecd.2012.04.011_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-4165(00)00188-4","article-title":"Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control","volume":"1526","author":"Carbo","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.numecd.2012.04.011_bib33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.febslet.2004.05.066","article-title":"Interleukin-15 is able to suppress the increased DNA fragmentation associated with muscle wasting in tumour-bearing rats","volume":"569","author":"Figueras","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.numecd.2012.04.011_bib34","first-page":"471","article-title":"Interleukin-15 decreases proteolysis in skeletal muscle: a direct effect","volume":"16","author":"Busquets","year":"2005","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.numecd.2012.04.011_bib35","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0016-5085(92)90021-P","article-title":"Effect of omega-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer","volume":"103","author":"Anti","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.numecd.2012.04.011_bib36","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/jnci\/85.21.1743","article-title":"Effects of dietary omega-3 fatty acids on human breast cancer growth and metastases in nude mice","volume":"85","author":"Rose","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.numecd.2012.04.011_bib37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0952-3278(93)90017-Q","article-title":"Mechanism of lipid mobilization associated with cancer cachexia: interaction between the polyunsaturated fatty acid, eicosapentaenoic acid, and inhibitory guanine nucleotide-regulatory protein","volume":"48","author":"Tisdale","year":"1993","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.numecd.2012.04.011_bib38","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1136\/gut.52.10.1479","article-title":"Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial","volume":"52","author":"Fearon","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.numecd.2012.04.011_bib39","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1200\/JCO.2005.04.5724","article-title":"Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia","volume":"24","author":"Fearon","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.numecd.2012.04.011_bib40","first-page":"CD004597","article-title":"Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia","author":"Dewey","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.numecd.2012.04.011_bib41","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.healun.2006.03.005","article-title":"Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure","volume":"25","author":"Mehra","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.numecd.2012.04.011_bib42","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1158\/0008-5472.CAN-04-0425","article-title":"Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting","volume":"64","author":"Busquets","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.numecd.2012.04.011_bib43","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.rmed.2004.07.003","article-title":"Past, present and future\u2013beta2-adrenoceptor agonists in asthma management","volume":"99","author":"Sears","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.numecd.2012.04.011_bib44","doi-asserted-by":"crossref","first-page":"H2587","DOI":"10.1152\/ajpheart.00985.2007","article-title":"Chronic beta2-adrenoceptor stimulation impairs cardiac relaxation via reduced SR Ca2+-ATPase protein and activity","volume":"294","author":"Ryall","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.numecd.2012.04.011_bib45","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijcard.2010.10.078","article-title":"Chronic formoterol administration reduces cardiac mitochondrial protein synthesis and oxidative capacity in mice","volume":"146","author":"L\u00e9ger","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.numecd.2012.04.011_bib46","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1210\/jc.2005-0275","article-title":"A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment","volume":"90","author":"Storer","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2012.04.011_bib47","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2217\/fon.09.106","article-title":"Nonsteroidal selective androgen receptor modulator ostarine in cancer cachexia","volume":"5","author":"Zilbermint","year":"2009","journal-title":"Future Oncol"},{"key":"10.1016\/j.numecd.2012.04.011_bib48","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/MCO.0b013e32832a3d79","article-title":"Selective androgen receptor modulators as function promoting therapies","volume":"12","author":"Bhasin","year":"2009","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.numecd.2012.04.011_bib49","first-page":"487","article-title":"Targeting myostatin for therapies against muscle-wasting disorders","volume":"11","author":"Tsuchida","year":"2008","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.1016\/j.numecd.2012.04.011_bib50","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.metabol.2006.05.009","article-title":"The effect of glutamine on prevention of glucocorticoid-induced skeletal muscle atrophy is associated with myostatin suppression","volume":"55","author":"Salehian","year":"2006","journal-title":"Metabolism"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475312001214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475312001214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T06:55:09Z","timestamp":1542869709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475312001214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":50,"alternative-id":["S0939475312001214"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2012.04.011","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms and treatment of cancer cachexia","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2012.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}